Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials
接受全直肠系膜切除术或选择性观察等待治疗后新辅助治疗患者的生存情况:CAO/ARO/AIO-12 和 OPRA 随机 II 期试验的汇总分析
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2025.01.006
Williams, H; Fokas, E; Diefenhardt, M; Lee, C; Verheij, F S; Omer, D M; Lin, S T; Dunne, R F; Marcet, J; Cataldo, P; Polite, B; Piso, P; Polat, B; Dapper, H; Ghadimi, M; Hofheinz, R D; Qin, L-X; Saltz, L B; Wu, A J; Gollub, M J; Smith, J J; Weiser, M R; Rödel, C; Garcia-Aguilar, J